Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE): 2014 update.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 25332362)

Published in CMAJ on October 20, 2014

Authors

Sheldon W Tobe1, James A Stone1, Kimberly M Walker1, Todd Anderson1, Onil Bhattacharyya1, Alice Y Y Cheng1, Jean Gregoire1, Gord Gubitz1, Mary L'Abbé1, David C W Lau1, Lawrence A Leiter1, Paul Oh1, Raj Padwal1, Luc Poirier1, Peter Selby1, Mark Tremblay1, Richard A Ward1, Diane Hua1, Peter P Liu2, C-CHANGE Initiative

Author Affiliations

1: Division of Nephrology (Tobe), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Libin Cardiovascular Institute of Alberta (Stone), University of Calgary, Cardiac Wellness Institute of Calgary, Calgary, Alta.; University Health Network, Toronto General Hospital (Walker), Toronto, Ont.; Libin Cardiovascular Institute of Alberta (Anderson), University of Calgary Calgary Alta.; Women's College Hospital (Bhattacharrya), University of Toronto, Toronto, Ont.; Division of Endocrinology and Metabolism (Cheng), St. Michael's Hospital, University of Toronto, Toronto, Ont.; Institut de cardiologie de Montréal (Gregoire), Université de Montréal, Montréal, Que.; Division of Neurology (Gubitz), Dalhousie University, Halifax, NS.; Department of Nutritional Sciences (L'Abbé), University of Toronto, Toronto, Ont.; Division of Endocrinology and Metabolism (Lau), Julia McFarlane Diabetes Research Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alta.; Keenan Research Centre (Leiter), Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ont.; Toronto Rehabilitation Institute (Oh), University Health Network, University of Toronto, Toronto, Ont.; Departments of Clinical Epidemiology and Pharmacology, and Division of General Internal Medicine (Padwal), University of Alberta, Edmonton, Alta.; Département de pharmacie, Centre Hospitalier Universitaire de Québec et Faculté de Pharmacie, Université Laval, Québec, Que.; Centre for Addiction and Mental Health, the Departments of Family and Community Medicine, and Psychiatry, and Dalla Lana School of Public Health (Selby), University of Toronto, Toronto, Ont.; The Children's Hospital of Eastern Ontario Research Institute (Tremblay), Ottawa, Ont.; the Department of Family Medicine (Ward), University of Calgary, Alta.; Sunnybrook Research Institute (Hua) Toronto, Ont.; University of Ottawa Heart Institute (Liu), Ottawa, Ont.
2: Division of Nephrology (Tobe), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.; Libin Cardiovascular Institute of Alberta (Stone), University of Calgary, Cardiac Wellness Institute of Calgary, Calgary, Alta.; University Health Network, Toronto General Hospital (Walker), Toronto, Ont.; Libin Cardiovascular Institute of Alberta (Anderson), University of Calgary Calgary Alta.; Women's College Hospital (Bhattacharrya), University of Toronto, Toronto, Ont.; Division of Endocrinology and Metabolism (Cheng), St. Michael's Hospital, University of Toronto, Toronto, Ont.; Institut de cardiologie de Montréal (Gregoire), Université de Montréal, Montréal, Que.; Division of Neurology (Gubitz), Dalhousie University, Halifax, NS.; Department of Nutritional Sciences (L'Abbé), University of Toronto, Toronto, Ont.; Division of Endocrinology and Metabolism (Lau), Julia McFarlane Diabetes Research Centre, Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alta.; Keenan Research Centre (Leiter), Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ont.; Toronto Rehabilitation Institute (Oh), University Health Network, University of Toronto, Toronto, Ont.; Departments of Clinical Epidemiology and Pharmacology, and Division of General Internal Medicine (Padwal), University of Alberta, Edmonton, Alta.; Département de pharmacie, Centre Hospitalier Universitaire de Québec et Faculté de Pharmacie, Université Laval, Québec, Que.; Centre for Addiction and Mental Health, the Departments of Family and Community Medicine, and Psychiatry, and Dalla Lana School of Public Health (Selby), University of Toronto, Toronto, Ont.; The Children's Hospital of Eastern Ontario Research Institute (Tremblay), Ottawa, Ont.; the Department of Family Medicine (Ward), University of Calgary, Alta.; Sunnybrook Research Institute (Hua) Toronto, Ont.; University of Ottawa Heart Institute (Liu), Ottawa, Ont. pliu@ottawaheart.ca.

Associated clinical trials:

Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) (CASP) | NCT03170752

Articles cited by this

Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess (2004) 29.45

Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ (1999) 14.34

2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ (2007) 9.10

AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ (2010) 8.73

2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol (2013) 5.97

Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak (2008) 5.28

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77

New Canadian physical activity guidelines. Appl Physiol Nutr Metab (2011) 3.57

Implementing clinical guidelines: current evidence and future implications. J Contin Educ Health Prof (2004) 3.26

How can we improve guideline use? A conceptual framework of implementability. Implement Sci (2011) 2.26

How to decide whether a clinical practice guideline is trustworthy. JAMA (2013) 2.24

Clinical practice guidelines: between science and art. CMAJ (1993) 2.02

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol (2013) 1.85

How evidence-based are the recommendations in evidence-based guidelines? PLoS Med (2007) 1.60

The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States. Can J Cardiol (2013) 1.50

Guidance for updating clinical practice guidelines: a systematic review of methodological handbooks. Implement Sci (2014) 1.30

Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative. CMAJ (2011) 1.12

The Canadian Diabetes Association 2013 clinical practice guidelines-raising the bar and setting higher standards! Can J Diabetes (2013) 0.85

Better guidelines for better care: enhancing the implementability of clinical practice guidelines. Expert Rev Pharmacoecon Outcomes Res (2011) 0.82